tiprankstipranks
Rocket Pharma (RCKT)
:RCKT
US Market

Rocket Pharmaceuticals (RCKT) Financial Statements

Compare
1,378 Followers

Rocket Pharmaceuticals Financial Overview

Rocket Pharmaceuticals's market cap is currently $711.22M. The company's EPS TTM is $-2.733; its P/E ratio is ―; Rocket Pharmaceuticals is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -7.10M$ -6.27M$ -5.37M$ -1.15M
Operating Income$ -273.20M$ -259.66M$ -224.34M$ -167.25M$ -134.30M
EBITDA$ -273.20M$ -236.62M$ -213.69M$ -161.72M$ -131.59M
Net Income$ -258.75M$ -245.59M$ -219.38M$ -169.59M$ -146.67M
Balance Sheet
Cash & Short-Term Investments$ 163.63M$ 373.18M$ 356.39M$ 388.74M$ 482.72M
Total Assets$ 527.70M$ 566.34M$ 551.81M$ 497.02M$ 590.82M
Total Debt$ 25.50M$ 25.04M$ 22.87M$ 22.60M$ 61.70M
Net Debt$ -138.14M$ -30.86M$ -117.65M$ -210.09M$ -235.40M
Total Liabilities$ 64.47M$ 73.77M$ 62.12M$ 42.30M$ 87.31M
Stockholders' Equity$ 463.23M$ 492.57M$ 489.69M$ 454.72M$ 503.52M
Cash Flow
Free Cash Flow$ -209.72M$ -211.39M$ -186.76M$ -128.88M$ -103.70M
Operating Cash Flow$ -209.72M$ -194.92M$ -178.14M$ -121.16M$ -74.64M
Investing Cash Flow$ 131.71M$ -98.07M$ -69.33M$ 18.85M$ -96.59M
Financing Cash Flow$ 185.74M$ 208.40M$ 155.29M$ 37.68K$ 282.99M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

Rocket Pharmaceuticals Debt to Assets

Rocket Pharmaceuticals Cash Flow

Rocket Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis